Cargando…
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma
BACKGROUND: Intratumoral immune infiltrates have manifested a robust prognostic signature in patients with hepatocellular carcinoma (HCC). We hypothesized that a novel tissue-related immune signature (TRIS) could improve the prediction of postoperative survival for patients diagnosed with early/inte...
Autores principales: | Tian, Meng-Xin, Liu, Wei-Ren, Wang, Han, Zhou, Yu-Fu, Jin, Lei, Jiang, Xi-Fei, Tao, Chen-Yang, Tang, Zheng, Zhou, Pei-Yun, Fang, Yuan, Qu, Wei-Feng, Ding, Zhen-Bin, Peng, Yuan-Fei, Dai, Zhi, Qiu, Shuang-Jian, Zhou, Jian, Lau, Wan Yee, Fan, Jia, Shi, Ying-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549297/ https://www.ncbi.nlm.nih.gov/pubmed/31164128 http://dx.doi.org/10.1186/s12916-019-1341-6 |
Ejemplares similares
-
Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis
por: Tao, Chen-Yang, et al.
Publicado: (2018) -
A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2018) -
CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma
por: Li, Li, et al.
Publicado: (2014) -
Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making
por: Zhang, Yong-Fa, et al.
Publicado: (2016) -
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)